申请人:JANSSEN PHARMACEUTICA NV
公开号:US09067917B2
公开(公告)日:2015-06-30
The present invention relates to compounds of Formula (I),
and solvates, hydrates, and pharmaceutically acceptable salts thereof, wherein ring A, R1, R5 and R6 are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.
本发明涉及式(I)化合物,其溶剂化物、水合物和药学上可接受的盐,其中环A,R1,R5和R6如所定义,可用作FLAP调节剂。本发明还涉及包含式(I)化合物的药物组合物。制备和使用式(I)化合物的方法也在本发明的范围内。